Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,575 | 168 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $459.55 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $324.67 | 18 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $269.83 | 18 | $0 (2023) |
| Lilly USA, LLC | $197.46 | 15 | $0 (2023) |
| AbbVie Inc. | $165.46 | 15 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $145.72 | 9 | $0 (2018) |
| PFIZER INC. | $136.74 | 9 | $0 (2024) |
| Amgen Inc. | $123.65 | 8 | $0 (2024) |
| SANOFI PASTEUR INC. | $117.09 | 5 | $0 (2024) |
| Amarin Pharma Inc. | $103.04 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $263.05 | 12 | Novo Nordisk Inc ($79.19) |
| 2023 | $314.32 | 24 | AbbVie Inc. ($145.66) |
| 2022 | $212.43 | 14 | Novo Nordisk Inc ($50.27) |
| 2021 | $345.69 | 23 | Novo Nordisk Inc ($120.06) |
| 2020 | $397.53 | 27 | Janssen Pharmaceuticals, Inc ($142.98) |
| 2019 | $344.07 | 20 | Janssen Pharmaceuticals, Inc ($82.52) |
| 2018 | $505.67 | 33 | Takeda Pharmaceuticals U.S.A., Inc. ($145.72) |
| 2017 | $192.60 | 15 | Janssen Pharmaceuticals, Inc ($37.48) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Obesity | ||||||
| 09/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Obesity | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Diabetes | ||||||
| 08/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: PAIN | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: PAIN | ||||||
| 03/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Gastroenterology | ||||||
| 02/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Bone Health | ||||||
| 01/31/2024 | SANOFI PASTEUR INC. | VAXELIS (Biological), BEYFORTUS | Food and Beverage | In-kind items and services | $39.17 | General |
| Category: Vaccines | ||||||
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Gastroenterology | ||||||
| 12/12/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Gastroenterology | ||||||
| 11/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2023 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Vaccines | ||||||
| 10/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 09/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/18/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 24 | 24 | $3,708 | $1,789 |
| 2022 | 2 | 30 | 31 | $4,185 | $2,478 |
| 2020 | 3 | 40 | 57 | $7,035 | $3,714 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $2,433 | $1,095 | 45.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $1,275 | $694.65 | 54.5% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 16 | 17 | $2,771 | $1,714 | 61.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 14 | 14 | $1,414 | $763.97 | 54.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 29 | $3,451 | $1,653 | 47.9% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 13 | 14 | $2,212 | $1,317 | 59.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 13 | 14 | $1,372 | $743.37 | 54.2% |
About Dr. Christopher Walker, M.D
Dr. Christopher Walker, M.D is a Physical Therapist healthcare provider based in Gonzales, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326225822.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Walker, M.D has received a total of $2,575 in payments from pharmaceutical and medical device companies, with $263.05 received in 2024. These payments were reported across 168 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,575).
As a Medicare-enrolled provider, Walker has provided services to 94 Medicare beneficiaries, totaling 112 services with total Medicare billing of $7,981. Data is available for 3 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Physical Therapist
- Other Specialties Family Medicine
- Location Gonzales, TX
- Active Since 01/28/2008
- Last Updated 04/16/2024
- Taxonomy Code 225100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326225822
Products in Payments
- XARELTO (Drug) $289.67
- Ozempic (Drug) $260.33
- FARXIGA (Drug) $184.04
- VRAYLAR (Drug) $120.30
- Amitiza (Drug) $103.42
- Vascepa (Drug) $103.04
- Prolia (Biological) $94.43
- JARDIANCE (Drug) $83.42
- XIFAXAN (Drug) $80.80
- Wegovy (Drug) $78.83
- TRULICITY (Drug) $72.75
- NURTEC ODT (Drug) $64.25
- LEQVIO (Drug) $57.16
- Rybelsus (Drug) $55.62
- SYMBICORT (Drug) $49.85
- EMGALITY (Drug) $42.56
- ENTRESTO (Drug) $41.98
- Saxenda (Drug) $41.82
- VAXELIS (Biological) $39.17
- REXULTI (Drug) $37.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Therapist Doctors in Gonzales
Mr. Raymond Dyer, Pt, PT
Physical Therapist
Jeff Shay, Mpt, MPT
Physical Therapist
Lindsey Harvey, Pt, PT
Physical Therapist
Mr. Robert Guidry, Physical Therapist, PHYSICAL THERAPIST
Physical Therapist
Ms. Renee Martin, Pt, PT
Physical Therapist
David Miranda, Pt, PT
Physical Therapist